Terug
18
Dagbereik
€ 0,33
€ 0,33
52-Weeksbereik
€ 0,27
€ 0,33
Volume
1.000
50D / 200D Gem.
€ 0,33
/
€ 0,32
Vorige Slotkoers
€ 0,33
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 5,6 | 0,3 |
| P/B | 0,2 | 3,0 |
| ROE % | 4,1 | 3,7 |
| Net Margin % | 8,7 | 3,8 |
| Rev Growth 5Y % | -28,4 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,07
€ 0,06 – € 0,10
|
2,17B | 1 |
| FY2027 |
€ 0,07
€ 0,06 – € 0,10
|
2,21B | 1 |
| FY2026 |
€ 0,06
€ 0,05 – € 0,09
|
2,06B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-23 | € 0,02 | € 0,00 | -74,5% |
| 2025-11-27 | N/A | € 0,00 | — |
| 2025-08-22 | N/A | € 0,00 | — |
| 2025-05-22 | N/A | € 0,00 | — |
| 2025-02-20 | N/A | € 0,00 | — |
| 2024-11-15 | N/A | € 0,00 | — |
| 2024-08-22 | N/A | € 0,00 | — |
| 2024-05-21 | N/A | € 0,00 | — |
Dividend History
Yield
0,01%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 16, 2025 | Dec 24, 2025 | € 0,00 | 1,47% |
| Dec 03, 2024 | Dec 12, 2024 | € 0,02 | 5,28% |
| Jun 21, 2024 | Jul 18, 2024 | € 0,00 | 3,52% |
| Mar 13, 2024 | Apr 08, 2024 | € 0,00 | 1,76% |
| Mar 07, 2023 | Mar 22, 2023 | € 0,01 | 3,41% |
| Apr 05, 2022 | Apr 22, 2022 | € 0,03 | 8,48% |
| Nov 08, 2021 | Nov 19, 2021 | € 0,03 | 9,18% |
| Aug 12, 2021 | Aug 26, 2021 | € 0,03 | 7,06% |
| May 06, 2021 | May 20, 2021 | € 0,03 | 4,24% |
| Mar 03, 2021 | Mar 17, 2021 | € 0,03 | 1,76% |
| Nov 24, 2020 | Dec 09, 2020 | € 0,01 | 1,77% |
| Jun 05, 2020 | Jun 19, 2020 | € 0,01 | 1,20% |
| Jan 07, 2020 | Jan 20, 2020 | € 0,01 | 1,21% |
| Jun 03, 2019 | Jun 21, 2019 | € 0,01 | 1,21% |
| Jan 16, 2019 | Jan 30, 2019 | € 0,01 | 1,24% |
| Jun 04, 2018 | Jul 03, 2018 | € 0,02 | 1,14% |
| Dec 15, 2017 | Jan 10, 2018 | € 0,01 | 1,70% |
| Jun 02, 2017 | Jul 05, 2017 | € 0,01 | 1,66% |
| Dec 15, 2016 | Jan 10, 2017 | € 0,01 | 1,75% |
| Jun 01, 2016 | Jul 05, 2016 | € 0,02 | 2,38% |
Belangrijkste Punten
Revenue declined -28,39% annually over 5 years
Earnings grew 27,58% over the past year
ROE of 4,11% is below average
Debt/Equity of 0,02 — conservative balance sheet
Generating 51,75M in free cash flow
P/E of 5,58 — trading at a low valuation
Groei
Revenue Growth (5Y)
-28,39%
Revenue (1Y)-8,53%
Earnings (1Y)27,58%
FCF Growth (3Y)-33,10%
Kwaliteit
Return on Equity
4,11%
ROIC2,63%
Net Margin8,66%
Op. Margin7,55%
Veiligheid
Debt / Equity
0,02
Current Ratio9,80
Interest Coverage94,74
Waardering
P/E Ratio
5,58
Forward P/EN/A
P/B Ratio0,23
EV/EBITDA-0,11
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -8,53% | Revenue Growth (3Y) | 4,70% |
| Earnings Growth (1Y) | 27,58% | Earnings Growth (3Y) | 236,45% |
| Revenue Growth (5Y) | -28,39% | Earnings Growth (5Y) | -52,04% |
| Profitability | |||
| Revenue (TTM) | 1,74B | Net Income (TTM) | 150,97M |
| ROE | 4,11% | ROA | 3,70% |
| Gross Margin | 7,55% | Operating Margin | 7,55% |
| Net Margin | 8,66% | Free Cash Flow (TTM) | 51,75M |
| ROIC | 2,63% | FCF Growth (3Y) | -33,10% |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 9,80 |
| Interest Coverage | 94,74 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 5,58 | Forward P/E | N/A |
| P/B Ratio | 0,23 | P/S Ratio | 0,48 |
| PEG Ratio | 0,84 | Forward PEG | N/A |
| EV/EBITDA | -0,11 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6,15% | ||
| Market Cap | 841,70M | Enterprise Value | -14,78M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,74B | 1,91B | 1,59B | 2,34B | 6,63B |
| Net Income | 150,97M | 118,34M | 13,34M | 157,10M | 2,85B |
| EPS (Diluted) | 0,06 | 0,05 | 0,01 | 0,06 | 1,12 |
| Gross Profit | 131,68M | 777,96M | 640,55M | 950,91M | 4,60B |
| Operating Income | 131,68M | 114,40M | 35,95M | 184,51M | 3,72B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,08B | 4,09B | 4,20B | 4,33B | 5,08B |
| Total Liabilities | 359,52M | 414,68M | 339,32M | 429,22M | 1,02B |
| Shareholders' Equity | 3,70B | 3,65B | 3,84B | 3,88B | 4,03B |
| Total Debt | 63,31M | 82,54M | 17,34M | 83,55M | 251,80M |
| Cash & Equivalents | 919,79M | 974,11M | 1,27B | 1,35B | 2,56B |
| Current Assets | 2,25B | 2,48B | 2,80B | 2,86B | 3,58B |
| Current Liabilities | 229,99M | 293,92M | 213,72M | 284,75M | 825,29M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#746 of 826
Recente Activiteit
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026